MINERAL: Magnetic Resonance Imaging and Quantitative Susceptibility Mapping (MRI-QSM) of brain iron to identify Chemotherapy-Associated Neurocognitive Impairment (CANI) in Acute Myeloid Leukaemia (AML).
Not Applicable
Recruiting
- Conditions
- Acute Myeloid LeukaemiaCancer - Leukaemia - Acute leukaemia
- Registration Number
- ACTRN12619000401156
- Lead Sponsor
- Metro North Hospital and Health Service
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Adults commencing induction chemotherapy for Acute Myeloid Leukaemia (AML).
Exclusion Criteria
Medical contraindications to MRI according to institutional policy;
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method